Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System
Background. Cutaneous squamous cell carcinoma is a common type of skin cancer, with aggressive metastatic or locally advanced disease representing an uncommon minority of presentations. Emerging data have supported the Food and Drug Administration approval of the anti-PD1 human monoclonal antibody c...
Main Authors: | Yuxin Liu MD, Bailey Fitzgerald MD, Edward Perry MD, Ashutosh Pathak MD, Herta H. Chao MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-05-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709619850216 |
Similar Items
-
Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407
by: Ying Cheng, MD, et al.
Published: (2021-10-01) -
Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
by: Anna L. Cogen, MD, PhD, et al.
Published: (2018-03-01) -
Spindle Cell Lipoma of the Thumb
by: Shogo Ebisudani, MD, PhD, et al.
Published: (2018-02-01) -
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma
by: Chase W. Kwon, MD, et al.
Published: (2020-10-01) -
Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
by: Hideo Oishi, MD, et al.
Published: (2020-10-01)